218.19
price up icon0.06%   0.21
 
loading
Precedente Chiudi:
$218.40
Aprire:
$219.34
Volume 24 ore:
273.29K
Relative Volume:
0.19
Capitalizzazione di mercato:
$31.66B
Reddito:
$5.54B
Utile/perdita netta:
$1.52B
Rapporto P/E:
21.03
EPS:
10.3734
Flusso di cassa netto:
$1.74B
1 W Prestazione:
+12.14%
1M Prestazione:
+11.48%
6M Prestazione:
-11.95%
1 anno Prestazione:
-14.77%
Intervallo 1D:
Value
$216.52
$219.98
Intervallo di 1 settimana:
Value
$196.99
$222.43
Portata 52W:
Value
$180.26
$293.81

Resmed Inc Stock (RMD) Company Profile

Name
Nome
Resmed Inc
Name
Telefono
(858) 746-2400
Name
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
Dipendente
10,600
Name
Cinguettio
@resmed
Name
Prossima data di guadagno
2026-07-30
Name
Ultimi documenti SEC
Name
RMD's Discussions on Twitter

Compare RMD vs ISRG, BDX, MDLN, ALC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
RMD icon
RMD
Resmed Inc
218.28 30.41B 5.54B 1.52B 1.74B 10.37
ISRG icon
ISRG
Intuitive Surgical Inc
429.38 150.88B 10.58B 3.00B 2.83B 8.2437
BDX icon
BDX
Becton Dickinson Co
157.50 43.56B 21.37B 1.41B 3.07B 3.9437
MDLN icon
MDLN
Medline Inc
42.96 36.52B 29.14B 1.07B 1.05B 1.1956
ALC icon
ALC
Alcon Inc
67.44 33.97B 10.63B 819.00M 1.59B 1.6577

Resmed Inc Stock (RMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-04-15 Iniziato JP Morgan Overweight
2025-12-16 Downgrade Robert W. Baird Outperform → Neutral
2025-09-18 Iniziato Citigroup Buy
2025-09-02 Aggiornamento CLSA Hold → Outperform
2025-07-15 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2025-03-19 Iniziato Morgan Stanley Overweight
2025-01-16 Iniziato Goldman Buy
2025-01-10 Iniziato Piper Sandler Neutral
2024-12-13 Iniziato Stifel Hold
2024-09-24 Iniziato Robert W. Baird Outperform
2024-09-18 Downgrade Wolfe Research Peer Perform → Underperform
2024-09-04 Downgrade Needham Buy → Hold
2024-06-25 Downgrade Oppenheimer Outperform → Perform
2024-06-24 Downgrade Citigroup Buy → Neutral
2024-02-06 Ripresa KeyBanc Capital Markets Overweight
2023-10-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-10-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-10-09 Aggiornamento JP Morgan Neutral → Overweight
2023-09-29 Downgrade Wolfe Research Outperform → Peer Perform
2023-09-06 Aggiornamento Needham Hold → Buy
2023-09-05 Downgrade UBS Buy → Neutral
2023-08-01 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-05-23 Iniziato UBS Buy
2023-04-14 Iniziato Mizuho Buy
2023-01-17 Aggiornamento JP Morgan Neutral → Overweight
2022-10-28 Downgrade Citigroup Buy → Neutral
2022-10-20 Aggiornamento BofA Securities Neutral → Buy
2022-10-12 Iniziato Jefferies Hold
2022-09-08 Aggiornamento Citigroup Neutral → Buy
2022-08-15 Downgrade CLSA Buy → Outperform
2022-08-12 Downgrade Citigroup Buy → Neutral
2022-08-12 Downgrade JP Morgan Overweight → Neutral
2022-08-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-06-06 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-04-06 Iniziato Wolfe Research Outperform
2022-01-31 Aggiornamento Citigroup Neutral → Buy
2022-01-31 Aggiornamento Goldman Neutral → Buy
2022-01-28 Aggiornamento RBC Capital Mkts Underperform → Sector Perform
2022-01-24 Aggiornamento BofA Securities Underperform → Neutral
2022-01-24 Aggiornamento JP Morgan Neutral → Overweight
2022-01-13 Aggiornamento CLSA Outperform → Buy
2022-01-13 Aggiornamento Robert W. Baird Neutral → Outperform
2021-12-21 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 Aggiornamento Macquarie Neutral → Outperform
2021-10-22 Aggiornamento CLSA Underperform → Outperform
2021-08-02 Downgrade CLSA Outperform → Sell
2021-08-02 Downgrade Needham Buy → Hold
2021-07-28 Aggiornamento Jefferies Underperform → Hold
2021-07-26 Downgrade JP Morgan Overweight → Neutral
2021-07-14 Iniziato RBC Capital Mkts Underperform
2021-06-28 Downgrade Citigroup Buy → Neutral
2021-06-22 Aggiornamento Macquarie Neutral → Outperform
2021-06-22 Iniziato Robert W. Baird Neutral
2021-06-21 Reiterato Needham Buy
2021-06-16 Downgrade BofA Securities Neutral → Underperform
2021-06-09 Aggiornamento CLSA Sell → Outperform
2021-05-21 Aggiornamento JP Morgan Neutral → Overweight
2021-05-11 Aggiornamento Citigroup Neutral → Buy
2021-04-30 Downgrade Citigroup Buy → Neutral
2021-03-16 Aggiornamento Needham Hold → Buy
2020-11-02 Aggiornamento UBS Neutral → Buy
2020-10-30 Aggiornamento JP Morgan Underweight → Neutral
2020-10-27 Aggiornamento BofA Securities Underperform → Neutral
2020-08-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-06-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-05-01 Downgrade JP Morgan Neutral → Underweight
2020-05-01 Aggiornamento Oppenheimer Perform → Outperform
2020-02-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-02-03 Iniziato CLSA Underperform
2020-01-31 Downgrade UBS Buy → Neutral
2020-01-10 Iniziato Oppenheimer Perform
2019-11-22 Iniziato KeyBanc Capital Markets Sector Weight
2019-07-29 Aggiornamento UBS Neutral → Buy
2019-07-16 Downgrade UBS Buy → Neutral
2019-05-06 Aggiornamento UBS Neutral → Buy
2019-04-18 Aggiornamento JP Morgan Underweight → Neutral
2019-01-25 Downgrade Goldman Buy → Neutral
2019-01-25 Downgrade JP Morgan Neutral → Underweight
2018-10-26 Aggiornamento Credit Suisse Neutral → Outperform
2018-07-02 Iniziato Goldman Buy
Mostra tutto

Resmed Inc Borsa (RMD) Ultime notizie

pulisher
10:21 AM

Form 144 RESMED INC For: 7 July By Investing.com - Investing.com Canada

10:21 AM
pulisher
10:11 AM

Michael Farrell to sell 4,991 RMD shares (NYSE: RMD) - Stock Titan

10:11 AM
pulisher
05:39 AM

ResMed stock trades on Nasdaq. Focus stays on sleep apnea demand. - AD HOC NEWS

05:39 AM
pulisher
12:41 PM

Why Resmed (RMD) Stock Is Up Today - Moomoo

12:41 PM
pulisher
Jul 06, 2026

ResMed Inc (RMD) Shares Surge 4.2% -- What GF Score of 90 Tells Investors - GuruFocus

Jul 06, 2026
pulisher
Jul 06, 2026

ResMed Inc. stock rises Monday, outperforms market - MarketWatch

Jul 06, 2026
pulisher
Jul 06, 2026

RMDResmed Inc Options - Finviz

Jul 06, 2026
pulisher
Jul 06, 2026

ResMed Inc. (RMD) Stock Analysis: A 24% Upside Potential With Robust Revenue Growth - DirectorsTalk Interviews

Jul 06, 2026
pulisher
Jul 05, 2026

Precision Trading with Resmed Inc. (RMD) Risk Zones - Stock Traders Daily

Jul 05, 2026
pulisher
Jul 03, 2026

Ord Minnett Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) - The Globe and Mail

Jul 03, 2026
pulisher
Jul 03, 2026

ResMed (RMD) Is Up 5.6% After Russell Growth Index Removal Amid Brighter Analyst Outlook - Sahm

Jul 03, 2026
pulisher
Jul 02, 2026

Why ResMed (RMD) Stock Is Trading Up Today - Yahoo Finance

Jul 02, 2026
pulisher
Jul 02, 2026

ResMed Inc. stock rises Thursday, outperforms market - MarketWatch

Jul 02, 2026
pulisher
Jul 01, 2026

ResMed (RMD) Added to Goldman Sachs' APAC Conviction List - GuruFocus

Jul 01, 2026
pulisher
Jul 01, 2026

Is It Too Late to Buy ResMed Inc (RMD) After 3.2% Rally? GF Value Says Undervalued - GuruFocus

Jul 01, 2026
pulisher
Jul 01, 2026

ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch

Jul 01, 2026
pulisher
Jul 01, 2026

ResMed (RMD) Upgraded to Buy: Here's Why - Yahoo Finance UK

Jul 01, 2026
pulisher
Jul 01, 2026

Wall Street Analysts Think ResMed (RMD) Could Surge 28.21%: Read This Before Placing a Bet - Yahoo! Finance Canada

Jul 01, 2026
pulisher
Jul 01, 2026

ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah — 1.94M shares - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

ResMed (RMD) Stock Looks Cheap Even As The Market Stays Cautious - Yahoo Finance

Jul 01, 2026
pulisher
Jun 30, 2026

Resmed to report Q4FY26 earnings on August 6, 2026 - scanx.trade

Jun 30, 2026
pulisher
Jun 30, 2026

Should ResMed’s Russell Growth Index Exit and Volatility Spike Require Action From ResMed (RMD) Investors? - Yahoo Finance

Jun 30, 2026
pulisher
Jun 30, 2026

ResMed Gets PTAB To Ax 1 Out Of 2 Sleep Apnea Patents - Law360

Jun 30, 2026
pulisher
Jun 30, 2026

ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch

Jun 30, 2026
pulisher
Jun 30, 2026

Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026 - The Manila Times

Jun 30, 2026
pulisher
Jun 30, 2026

ResMed Inc options activity points to a potential volatility spike. Consensus earnings expectations - AD HOC NEWS

Jun 30, 2026
pulisher
Jun 29, 2026

ResMed leads sleep apnea market with strong growth and margin improvements, rated Buy with 12% safety margin. - Pluang

Jun 29, 2026
pulisher
Jun 29, 2026

ResMed: Fear-Driven Selloff Creates A Compelling Margin Of Safety Entry Point - Seeking Alpha

Jun 29, 2026
pulisher
Jun 29, 2026

ResMed Inc.(NYSE: RMD) dropped from Russell Midcap Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Are Options Traders Betting on a Big Move in ResMed Stock? - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

ResMed adjusts index footprint, shares hold gains on NYSE and ASX - AD HOC NEWS

Jun 29, 2026
pulisher
Jun 28, 2026

ResMed Inc.(NYSE: RMD) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

ResMed Inc.(NYSE: RMD) dropped from Russell 1000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Daily Brief Australia: Cochlear Ltd, Commonwealth Bank of Australia, Fortescue Metals, ResMed Inc and more - Smartkarma

Jun 28, 2026
pulisher
Jun 28, 2026

ResMed Inc.(NYSE: RMD) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

AirSense 10 ClimateLineAir Heated Tube from ResMed Inc.quieter nights with smarter humidity - Ad-hoc-news.de

Jun 28, 2026
pulisher
Jun 28, 2026

ResMed muted ahead of next earnings, shares trade steadily on NYSE - Ad-hoc-news.de

Jun 28, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of ResMed Inc. – NYSE:RMD - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

OLD National Bancorp IN Has $4.58 Million Position in ResMed Inc. $RMD - MarketBeat

Jun 27, 2026
pulisher
Jun 27, 2026

ResMed Inc. sees fresh institutional buying, shares hover near 200 dollars - Ad-hoc-news.de

Jun 27, 2026
pulisher
Jun 27, 2026

ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

Price to earnings forward of ResMed Inc. – NYSE:RMD - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to earnings forward of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – MUN:RMEA - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to sales forward of ResMed Inc. – NYSE:RMD - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

ResMed clears key trading range, shares hold firm between support and resistance - Ad-hoc-news.de

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to revenue forward of ResMed Inc. – NYSE:RMD - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Should you continue to hold Resmed stock in your portfolio? - MSN

Jun 25, 2026
pulisher
Jun 25, 2026

ResMed clears a fresh 52-week high, shares extend their Nasdaq run - Ad-hoc-news.de

Jun 25, 2026
pulisher
Jun 25, 2026

Why ResMed Inc (RMD) Is Set to Outperform the Market: Insights i - GuruFocus

Jun 25, 2026
pulisher
Jun 25, 2026

Price to book forward of ResMed Inc. – NYSE:RMD - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

ResMed Stock is Down 20% in 2026. Is It a Buying Opportunity or a Warning Sign? - TIKR.com

Jun 25, 2026

Resmed Inc Azioni (RMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Resmed Inc Azioni (RMD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Farrell Michael J.
Chairman and CEO
Jun 08 '26
Sale
193.96
4,991
968,064
466,256
ALC ALC
$67.48
price down icon 1.32%
$42.90
price up icon 0.32%
WST WST
$353.32
price down icon 1.18%
BDX BDX
$157.67
price up icon 1.35%
COO COO
$72.66
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):